<DOC>
	<DOCNO>NCT03084744</DOCNO>
	<brief_summary>To compare efficacy schema therapy versus active monitoring woman chronic depression receive psychiatric care .</brief_summary>
	<brief_title>Schema Therapy Chronic Depression</brief_title>
	<detailed_description>A randomized , assessor-blind , single center , superiority trial conduct . Participants refer clinical psychologist private counseling office ( Senzoku Stress Coping Support Office , Japan ) . Eligible participant woman chronic depression receive psychiatric care . Participants receive schema therapy active monitoring 2 year . Primary outcome treatment response . A total sample size 64 ( 32 group ) would require provide 80 % power 2-sided significance level 5 % detect risk difference 35 % ( response rate : 55 % schema therapy vs. 20 % active monitoring ) , assume dropout rate 10 % .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Dysthymic Disorder</mesh_term>
	<criteria>Persistent depressive disorder include chronic major depressive disorder dysthymic disorder assess Structured Clinical Interview DSM Scores least 14 GRIDHAMD Psychiatric treatment duration depression least 3 year Psychiatric hospitalization within 30 day prior enrollment Ineligible receive protocol treatment 2 year Schizophrenia Bipolar disorder Intellectual disability Neurocognitive disorder Substancerelated disorder</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>